Publications by authors named "Angel Brea"

Claim this Profile
I
Implementation of a biochemical, clinical, and genetic screening programme for familial hypercholesterolemia in 26 centres in Spain: The ARIAN study.
Teresa Arrobas Velilla, Ángel Brea, Pedro Valdivielso

Front Genet· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implantation of a biochemical and genetic screening programme for family hypercholesterolaemia. Collaboration between the clinical laboratory and lipid units: Design of the ARIAN Project.
Teresa Arrobas Velilla, Ángel Brea, Pedro Valdivielso, ,

Clin Investig Arterioscler· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias.
Juan Pedro-Botet, Juan F Ascaso, Mariano Blasco, Ángel Brea, Ángel Díaz

Clin Investig Arterioscler· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atherogenic Dyslipidaemia 2019. Consensus document of the Atherogenic Dyslipidaemia Group of the Spanish Arteriosclerosis Society.
Juan F Ascaso, Jesús Millán, Antonio Hernández-Mijares, Mariano Blasco, Ángel Brea

Clin Investig Arterioscler· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternally inherited hypercholesterolemia does not modify the cardiovascular phenotype in familial hypercholesterolemia.
Victoria Marco-Benedí, Martín Laclaustra, Ana M Bea, Manuel Suarez-Tembra, Núria Plana, Angel Brea

Atherosclerosis· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA Study.
Bárbara Fernández-Cidón, Beatriz Candás-Estébanez, Miriam Gil-Serret, Núria Amigó, Emili Corbella, Angel J Brea

J Clin Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry.
Leopoldo Pérez de Isla, Raquel Arroyo-Olivares, Rodrigo Alonso, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, Ángel Brea

Rev Esp Cardiol (Engl Ed)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-HDL cholesterol as a therapeutic goal.
Angel Brea, Antonio Hernández-Mijares, Jesús Millán, Juan F Ascaso, Mariano Blasco

Clin Investig Arterioscler· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual cardiovascular risk of lipid origin. Components and pathophysiological aspects.
Antonio Hernández-Mijares, Juan F Ascaso, Mariano Blasco, Ángel Brea, Ángel Díaz

Clin Investig Arterioscler· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrates in primary prevention of cardiovascular disease. Comments on the results of a systematic review of the Cochrane Collaboration.
Angel Brea, Jesús Millán, Juan F Ascaso, Mariano Blasco, Angel Díaz

Clin Investig Arterioscler· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease.
Ángel Brea, Xavier Pintó, Juan F Ascaso, Mariano Blasco, Ángel Díaz

Clin Investig Arterioscler· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (I). Nonalcoholic fatty liver disease and its association with cardiovascular disease.
Ángel Brea, Xavier Pintó, Juan F Ascaso, Mariano Blasco, Ángel Díaz

Clin Investig Arterioscler· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrates in the secondary prevention of cardiovascular disease (infarction and stroke). Results of a systematic review and meta-analysis of the Cochrane collaboration.
Jesus Millan, Xavier Pintó, Angel Brea, Mariano Blasco, Antonio Hernández-Mijares

Clin Investig Arterioscler· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus document on the management of the atherogenic dyslipidaemia of the Spanish Society of Arteriosclerosis.
Juan F Ascaso, Jesús Millán, Antonio Hernández-Mijares, Mariano Blasco, Ángel Brea

Clin Investig Arterioscler· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Fibrates therapy: Rational use fenofibrate 2016. Executive summary].
Angel Brea, Jesús Millán, Juan F Ascaso, Mariano Blasco, Angel Díaz

Clin Investig Arterioscler· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The real measurement of non-HDL-cholesterol: Atherogenic cholesterol].
Jesús Millán, Antonio Hernández-Mijares, Juan F Ascaso, Mariano Blasco, Angel Brea

Clin Investig Arterioscler· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
Leopoldo Pérez de Isla, Rodrigo Alonso, Nelva Mata, Cristina Fernández-Pérez, Ovidio Muñiz, Ángel Brea

Circulation· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of the Definition of Severe Familial Hypercholesterolemia for Stratification of Heterozygous Patients.
Sofia Pérez-Calahorra, Rosa María Sánchez-Hernández, Núria Plana, Victoria Marco-Benedi, Juan Pedro-Botet, Angel Brea

Am J Cardiol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine.
Isabel De Castro-Orós, Rosa Solà, Rosa María Valls, Angel Brea, Pilar Mozas

PLoS One· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study.
Francisco Fuentes, Juan F Alcala-Diaz, Gerald F Watts, Rodrigo Alonso, Ovidio Muñiz, Ángel Brea

Int J Cardiol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Epidemiology of cerebrovascular disease in Spain].
Angel Brea, Martín Laclaustra, Esperanza Martorell, Angels Pedragosa

Clin Investig Arterioscler· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Decalogue of clinical recommendations on atherogenic dyslipidemia].
Juan Pedro-Botet, Jesús Millán, Ángel Brea, Ángel Díaz, Pedro González-Santos

Clin Investig Arterioscler· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial.
Rosa Solà, Rosa-M Valls, José Puzo, José-Ramón Calabuig, Angel Brea

PLoS One· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in a cohort of familial hypercholesterolemia patients from the south of Europe.
Nelva Mata, Rodrigo Alonso, Jose R Banegas, Daniel Zambón, Angel Brea

Eur J Public Health· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-alcoholic fatty liver disease and cardiovascular risk.
Angel Brea, José Puzo

Int J Cardiol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis